[Form 4] Angi Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kris Boon, Chief Product Officer of Angi Inc. (ANGI), received a grant of 72,500 restricted stock units on 09/17/2025 that convert to Class A common shares upon vesting. The award is reported as direct ownership of 72,500 shares following the grant. The RSUs vest in three installments: approximately 21% on March 1, 2027, 21% on March 1, 2028, and 59% on March 1, 2029, subject to continued service. The Form 4 was signed by an attorney-in-fact on 09/18/2025. Each RSU represents a contingent right to one share of Class A common stock.

Insights

Securities Analyst

TL;DR: Routine executive equity award aligns management with shareholders; modest near-term vesting delays limit immediate dilution.

This Form 4 discloses a time-based grant of 72,500 restricted stock units to the Chief Product Officer, reported as direct beneficial ownership. The vesting schedule is back-loaded with the largest tranche (59%) in 2029, which emphasizes retention over immediate share issuance. For investors, this is a standard compensation mechanism linking executive incentives to long-term share performance rather than an event likely to materially change capital structure in the near term.

Compensation & Governance Specialist

TL;DR: Grant design favors retention through multi-year cliff-like schedule; governance implications are typical for senior executives.

The award’s three-point vesting (21%/21%/59%) is consistent with retention-focused packages. The Form 4 shows direct beneficial ownership equal to the full award immediately for reporting purposes, but actual share issuance depends on continued service through vesting dates. No accelerated vesting, sale, or derivative transactions are disclosed. This is a routine disclosure under Section 16 reporting requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Boon Kris

(Last) (First) (Middle)

C/O ANGI INC.

3601 WALNUT STREET, SUITE 700

(Street)

DENVER CO 80205

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Angi Inc. [ ANGI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	09/17/2025		A		72,500		(2)	(2)	Class A Common Stock, par value $0.001	72,500	$0	72,500	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock.

2. Approximately twenty-one percent (21%), twenty-one percent (21%) and fifty-nine percent (59%) of the restricted stock units vest on March 1, 2027, March 1, 2028 and March 1, 2029, respectively, such that the award will be fully vested on March 1, 2029, subject to continued service.

Remarks:

	/s/ Shannon M. Shaw, as Attorney-in-Fact for Kris Boon	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.